Tenecteplase: Clinical Trials

2 trials of Tenecteplase, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 withdrawn. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Not yet recruiting 1, Withdrawn 1

Follow Tenecteplase: new trials by email Literature Review of Tenecteplase trials Research Report on Tenecteplase

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Of A Second Dose Of Tenecteplase In Selected Acute Ischemic Stroke Patients Not Responding To The First Dose
Tenecteplase (TNK) (0.25 mg/kg, to maximum of 25mg) - Acute Ischemic Stroke
Phase 1Not yet recruitingMemorial Hermann Health System202025-07-012025-06-05
Treatment of Acute Respiratory Distress Syndrome With Tenecteplase: A Dose Escalation Pilot Study
Tenecteplase - Acute Respiratory Distress Syndrome
Phase 1WithdrawnWake Forest University Health Sciences2007-02-012024-10-16

Conditions studied

Ischemic Stroke (1)  ·  Respiratory Distress Syndrome (1)  ·  Stroke (1)

Sponsors

Memorial Hermann Health System (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (2)

Top investigators

Debra M Kitchens, RN, CEN (1)  ·  Dennis W. Ashley, MD, FACS (1)